Jan Hoflack

Founder at ONCODESIGN PRECISION MEDICINE

66 year

Health Technology

Commercial Services

Consumer Services

Profile

Jan Hoflack is the founder of Pharmopsis BV, founded in 2010, where the title held was Deputy Chief Executive Officer.
Dr. Hoflack is the founder of Oncodesign Precision Medicine SA, founded in 2020, holding the titles of Director, Chief Scientific Officer & Deputy MD.
The current job is Chief Scientific Officer & General Manager at Oncodesign SA, starting in 2009.
Former jobs include External Director at GNI Group Ltd. and Vice President-Medicinal Chemistry at Johnson & Johnson Pharmaceutical Research & Development LLC.
Education includes a doctorate from Ghent University.

Jan Hoflack active positions

Companies	Position	Start
ONCODESIGN	Chief Tech/Sci/R&D Officer	-
ONCODESIGN PRECISION MEDICINE	Founder	14/12/2020

All active positions of Jan Hoflack

Former positions of Jan Hoflack

Companies	Position	End
Pharmopsis BV	Founder	-
Johnson & Johnson Pharmaceutical Research & Development LLC Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services	Corporate Officer/Principal	-
GNI GROUP LTD.	Director/Board Member	-

See the detail of Jan Hoflack's experience

Training of Jan Hoflack

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Jan Hoflack's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	6
Johnson & Johnson Pharmaceutical Research & Development LLC Johnson & Johnson Pharmaceutical Research & Development LLC Miscellaneous Commercial ServicesCommercial Services Provides providing research and development support services	Commercial Services
Ghent University Ghent University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Oncodesign SA Oncodesign SA BiotechnologyHealth Technology Develops preclinical evaluation of novel anticancer therapies	Health Technology
GNI Group Ltd. GNI Group Ltd. BiotechnologyHealth Technology Engages in research and development, manufacture and sale of pharmaceutical products	Health Technology
Pharmopsis BV
Oncodesign Precision Medicine SA Oncodesign Precision Medicine SA Pharmaceuticals: MajorHealth Technology Discovers and develops new molecules for the health treatments in oncology	Health Technology